TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood vessel disease: drug shows promise in small trial
Disease control CompletedThis study tested the drug upadacitinib in 12 people with Takayasu arteritis, a rare disease where the body's immune system attacks large blood vessels. The goal was to see if the drug could help control the disease in patients who did not get better with standard treatments. The…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Liu Tian • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Could a tiny dose of an alcoholism drug ease vasculitis pain?
Symptom relief CompletedThis study tested whether a very low dose of naltrexone, a drug already approved for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare diseases causing blood vessel inflammation). Sixty adults with different types of vasculitis…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 26, 2026 10:43 UTC
-
Surgery boosts survival in rare artery disease
Knowledge-focused CompletedThis study looked at 78 people with Takayasu arteritis, a rare disease that narrows major arteries. It compared those who had surgery to open narrowed blood vessels with those who only took medication. The goal was to see which approach helped people live longer.
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 10:48 UTC